© ANZDATA Registry Stock and Flow of CAPD Patients Australia 1991-1998 Number of Patients 1504 Patients 91 92 93 94 95 96 97 98 * (Data to 30 Sept) Extrapolated.

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
© ANZDATA Registry CANCER CHAPTER CHAPTER 10. © ANZDATA Registry CharacteristicMyelomaNon-Myeloma n%n% Total (%)807153,37199 Country of residence Australia ,25683.
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
Kidney Donors ANZDATA Annual Report 2014 Chapter 9.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Parathyroidectomy Danish Renal Registry James Heaf.
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
First-year death rates by modality figure 8
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 18th Annual Report
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 7 Nutritional Status on Dialysis
ANZDATA 2014 Annual Report Chapter 11
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
Volume 64, Pages S3-S12 (December 2003)
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Volume 73, Issue 4, Pages (February 2008)
French peritoneal dialysis registry (RDPLF): Outline and main results
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
Peritoneal dialysis adequacy and risk of death
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
American Journal of Kidney Diseases
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Update from the Haemodialysis Working Group
Figure 1. Mean insulin requirement per day in 16 hemodialysis, 18 hemofiltration, 26 continuous ambulatory peritoneal dialysis (CAPD), and 14 intermittent.
Dialysis outcomes in Australia & New Zealand
ANZDATA Peritoneal Dialysis Report
Stock and Flow of Haemodialysis Patients Australia
ANZDATA: Vascular Access
Stock and Flow of Peritoneal Dialysis Patients Australia
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated * * CAPDA.BRIS99

© ANZDATA Registry Stock and Flow of CAPD Patients New Zealand Number of Patients 594 Patients * (Data to 30 Sept) Extrapolated * * CAPDNZ.BRIS99

© ANZDATA Registry Relationship of BMI to Weekly Dialysate Volume Australia BMI   BMIAUST.BRIS99

© ANZDATA Registry Relationship of BMI to Weekly Dialysate Volume New Zealand BMI   BMINZ.BRIS99

© ANZDATA Registry Peritoneal Dialysis Technique Failure Events / Deaths per 100 Years at Risk Peritoneal Dialysis Technique Failure Events / Deaths per 100 Years at Risk * Data to 30 Sept Australia

© ANZDATA Registry Peritoneal Dialysis Technique Failure Events / Deaths per 100 Years at Risk Peritoneal Dialysis Technique Failure Events / Deaths per 100 Years at Risk * Data to 30 Sept New Zealand

© ANZDATA Registry Causes of Technique Failure 1-Apr-94 to 30-Sep-98

© ANZDATA Registry Annual Death Rate Per 100 Patient Years Mode of Dialysis Australia * CAPD HD Deaths Pts Risk Non Diabetic * Data to 30 Sept

© ANZDATA Registry Annual Death Rate Per 100 Patient Years Mode of Dialysis Australia * CAPD HD Deaths Pts Risk Diabetic * Data to 30 Sept

© ANZDATA Registry Annual Death Rate Per 100 Patient Years Mode of Dialysis New Zealand * CAPD HD Deaths Pts Risk Non Diabetic * Data to 30 Sept

© ANZDATA Registry Annual Death Rate Per 100 Patient Years Mode of Dialysis New Zealand * CAPD HD Deaths Pts Risk Diabetic * Data to 30 Sept

© ANZDATA Registry Comorbid Risk Factors * Treatment at 90 Days Australia Comorbid Risk Factors * Treatment at 90 Days Australia * Data to 30 Sept % Patients = Yes

© ANZDATA Registry Comorbid Risk Factors * Treatment at 90 Days Australia Comorbid Risk Factors * Treatment at 90 Days Australia * Data to 30 Sept % Patients = Suspected

© ANZDATA Registry Comorbid Risk Factors * Treatment at 90 Days New Zealand Comorbid Risk Factors * Treatment at 90 Days New Zealand * Data to 30 Sept % Patients = Yes

© ANZDATA Registry Comorbid Risk Factors * Treatment at 90 Days New Zealand Comorbid Risk Factors * Treatment at 90 Days New Zealand * Data to 30 Sept % Patients = Suspected